Cartesian Therapeutics (RNAC) Debt to Equity (2015 - 2023)
Cartesian Therapeutics (RNAC) reported Debt to Equity of -$0.06 for Q4 2023, down 133.92% year-over-year from $0.19 in Q4 2022, and down 117.52% quarter-over-quarter from $0.37 in Q2 2023.
Cartesian Therapeutics (RNAC) Debt to Equity (2015 - 2023) Analysis & Trends
Cartesian Therapeutics (RNAC) has 9 years of Debt to Equity data on file, last reported at -$0.06 in Q4 2023.
- Debt to Equity for Q4 2023 came in at -$0.06, down 133.92% year-over-year; the trailing twelve-month figure through Dec 2023 was -$0.06 (down 133.92% YoY), and the FY2023 annual result was -$0.06, down 133.92% from the prior year.
- Debt to Equity retreated to -$0.06 in Q4 2023 per RNAC's latest filing, from $0.37 in the prior quarter.
- Over five years, Debt to Equity peaked at $384.79 in Q2 2019 and troughed at -$5.97 in Q2 2021.
- A 5-year average of $19.52 and a median of $0.19 in 2022 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2019 and 2021: Debt to Equity jumped 39198.5% in 2019, then slumped 425.67% in 2021.
- A 5-year view of Debt to Equity shows it stood at $2.25 in 2019, then sank by 161.16% to -$1.38 in 2020, then soared by 182.66% to $1.14 in 2021, then sank by 83.35% to $0.19 in 2022, then sank by 133.92% to -$0.06 in 2023.
- Business Quant data shows RNAC's Debt to Equity at -$0.06 in Q4 2023, $0.37 in Q2 2023, and $0.35 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.06 |
| Jun 30, 2023 | 0.37 |
| Mar 31, 2023 | 0.35 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.31 |
| Jun 30, 2022 | 0.29 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 1.14 |
| Sep 30, 2021 | -1.36 |
| Jun 30, 2021 | -5.97 |
| Mar 31, 2021 | -1.28 |
| Dec 31, 2020 | -1.38 |
| Sep 30, 2020 | -3.33 |
| Jun 30, 2020 | -1.14 |
| Mar 31, 2020 | -1.92 |
| Dec 31, 2019 | 2.25 |
| Sep 30, 2019 | -4.26 |
| Jun 30, 2019 | 384.79 |
| Mar 31, 2019 | 1.45 |
| Dec 31, 2018 | -3.95 |